ReviewBioengineered
Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.
Bernd Groner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
cites it